Electroconvulsive therapy (ECT) has an important role in the treatment of patients with severe depression or schizophrenia. ECT results in an acute cardiovascular response, characterized by tachycardia, hypertension and increase in cerebral artery blood flow velocity (V mca) [1]. For patients at risk of cardiovascular complications, b-adrenergic blocking agents are often administered to prevent or minimize the increase in blood pressure (BP) and heart rate (HR). The aim of this study was to evaluate the effects of two different b-blockers, esmolol and labetalol, on changes in V mca during ECT using transcranial Doppler (TCD). In a prospective, randomized study, 37 patients undergoing ECT were evaluated. The study was approved by the Stanford Institutional Review Board, and written informed consent was obtained. Anaesthesia was induced with etomidate (0.25 mg kg 21) and succinylcholine (1 mg kg 21). Monitoring consisted of electrocardiogram, BP (non-invasive) and pulse oximetry. In addition, V mca (Neuroguard, MedaSonics, Fremont, CA, USA) of the left middle cerebral artery was measured, using a 2 MHz ultrasonic wave. Patients without pre-existing hypertension (mean arterial pressure (MAP) , 85 mmHg) received no b-blockers (Group N 5 12 patients). Patients with pre-existing hypertension (MAP. 85 mmHg) were, at random, pre-treated with either esmolol (Group E 5 13 patients) or labetalol (Group L 5 12 patients) intravenously to lower MAP to ,85 mmHg. The TCD technician was blinded for the treatment compounds. After induction of anaesthesia, all patients were manually hyperventilated with 100% O 2 for 30 s. ECT was applied when nerve stimulation of the ulnar and radial nerves showed absent twitches, and the patellar reflex was negative. All patients underwent bilateral ECT. V mca , HR and MAP were measured just before induction of anaesthesia (baseline), and at 0.5, 5, 10 and 30 min post-ECT. Data were analysed by one-way analysis of variance on ranks. Dunn's method was used for